CLOV vs OKUR · rev $1.37B vs P/E 72, $76.6M cap
Clover Health Investments Corp (CLOV) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported OKUR revenue for 2024-12-31 was $0. Net income was -$52.7M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
CLOV currently screens at market cap $1.55B. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the CLOV and OKUR stock pages for the full models.
Not investment advice.